News
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the second quarter 2025, in conjunction with their partner Biogen's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback